Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease

The presentation will summarize the most important findings explaining what biofluid-based tau protein concentrations reflect and how these markers can be used alongside tau-PET to improve the diagnostics, staging and therapy-monitoring in AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_099493
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease

Kaj Blennow, Henrik Zetterberg
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease

Kaj Blennow, Henrik Zetterberg
article en

Abstract

The presentation will summarize the most important findings explaining what biofluid-based tau protein concentrations reflect and how these markers can be used alongside tau-PET to improve the diagnostics, staging and therapy-monitoring in AD.

Alzheimer s & DementiaVol. 21(S2)
Profu (Sweden) (SE), University of Gothenburg (SE)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease — Kaj Blennow, Henrik Zetterberg · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS